The Incidence and Risk Factors for Adverse Drug Reactions Related to Tanreqing Injection: A Large Population-Based Study in China

The Incidence and Risk Factors for Adverse Drug Reactions Related to Tanreqing Injection: A Large Population-Based Study in China

Background: Tanreqing injection (TRQ) is a traditional Chinese medicine commonly used in China to treat pulmonary diseases presenting as phlegm-heat syndrome. Robust data on the safety of TRQ from real-world observational cohorts are currently lacking.Objective: To evaluate as the incidence, type, a...

Full description

Bibliographic Details
Main Authors:	Xiao-Xiao Li, Lin Zhuo, Yan Zhang, Yi-Heng Yang, Hong Zhang, Si-Yan Zhan, Suo-Di Zhai
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-01-01
Series:	Frontiers in Pharmacology
Subjects:	drug safety adverse drug reactions pharmacovigilance anaphylaxis traditional Chinese medicine off-label
Online Access:	https://www.frontiersin.org/article/10.3389/fphar.2019.01523/full

Similar Items

Indication and adverse event profiles of denosumab and zoledronic acid: based on U.S. FDA adverse event reporting system (FAERS)
by: Si Su, et al.
Published: (2023-11-01)

Retrospective Analysis of Spontaneous Reports of Fatal Adverse Reactions Associated with Lidocaine
by: A. V. Matveev, et al.
Published: (2024-04-01)

EVALUATION OF SAFETY OF DRUG THERAPY IN CLINICAL PRACTICE
by: M. N. Kostyleva, et al.
Published: (2015-03-01)

Adverse reactions by antibiotics and non-steroidal anti-inflammatory drugs
by: Karen Orellana, et al.
Published: (2022-03-01)

Age-Associated Risk of Liver-Related Adverse Drug Reactions
by: Yan-zhong Han, et al.
Published: (2022-03-01)

Role of hospital pharmacists in reporting adverse drug reactions – A review
by: Sharmila P Nirojini, et al.
Published: (2012-01-01)

Reporting of adverse events for marketed drugs: Need for strengthening safety database
by: Aditi Anand Apte
Published: (2016-01-01)

Adverse drug reactions among patients admitted with infectious diseases at a Brazilian hospital
by: Pamela Alejandra Saavedra, et al.

Analysis of drug-induced anaphylaxis cases using the Japanese Adverse Drug Event Report (JADER) database – secondary publication
by: Chizuko Sugizaki, et al.
Published: (2023-10-01)

Adverse drug reactions and drug interactions in the treatment of hospitalized patients with coronavirus disease 2019 (COVID-19)
by: Tatiana A. Marins, et al.
Published: (2021-01-01)

Common causes and characteristics of adverse drug reactions in older adults: a retrospective study
by: Seong-Dae Woo, et al.
Published: (2020-12-01)

A real-world study of antifibrotic drugs-related adverse events based on the United States food and drug administration adverse event reporting system and VigiAccess databases
by: Menglin He, et al.
Published: (2024-02-01)

Adverse Drug Reactions of Antiepileptic Drugs in Neurology Department of M.Y.H Indore, India: An Observational, Prospective Study
by: Saman Hussain, et al.
Published: (2023-04-01)

Investigation of the characteristics of medication errors and adverse drug reactions using pharmacovigilance data in China
by: Xiaofang Tan, et al.
Published: (2020-10-01)

Adverse Drug Reaction and Its Predictors Among Psychiatric Patients Taking Psychotropic Medications at the Mizan-Tepi University Teaching Hospital
by: Ejeta F, et al.
Published: (2021-12-01)

A 5 year retrospective analysis of adverse drug reactions associated with antimicrobials in a teaching hospital of Andaman and Nicobar islands
by: Mangesh Bankar, et al.
Published: (2021-11-01)

Physician's knowledge and experience with the off-label use of medicines
by: Maria Drenska, et al.
Published: (2021-01-01)

Adverse Drug Reactions in Mazandaran Province, Iran, 2004-2018
by: Fatemeh Izadpanah, et al.
Published: (2020-05-01)

A 5 year retrospective analysis of pharmacovigilance study, completeness and quality of suspected adverse drug reaction forms at adverse drug reaction monitoring center Port Blair.
by: Priyanka Hotha, et al.
Published: (2021-12-01)

Jordanians' knowledge, attitude and practice regarding adverse drug reactions reporting
by: Faris El-Dahiyat, et al.
Published: (2023-07-01)

Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients
by: Alan O. Vázquez-Alvarez, et al.
Published: (2017-12-01)

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
by: Han N, et al.
Published: (2021-08-01)

Pharmacovigilance: Scope for a dermatologist
by: Bhanu Prakash, et al.
Published: (2011-01-01)

Qualitative Study of General Public Views towards Adverse Drug Reactions in Lithuania
by: Agne Valinciute-Jankauskiene, et al.
Published: (2021-03-01)

The evaluation of adverse drug reactions in Saudi Arabia: A retrospective observational study
by: Khalidah A. Alenzi, et al.
Published: (2022-06-01)

Adverse drug reaction profile in Amravati region of India: A pharmacovigilance study
by: Kishor A Bansod, et al.
Published: (2020-01-01)

An analysis of adverse drug reactions in extremes of age group at tertiary care teaching hospital
by: Saloni Amin, et al.
Published: (2018-01-01)

Reporting of adverse drug reactions due to cardiovascular drugs in India: A national duty
by: Vivekanandan Kalaiselvan
Published: (2015-11-01)

A real-world pharmacovigilance analysis of FDA adverse event reporting system database for upadacitinib
by: Yan Wu, et al.
Published: (2023-08-01)

ANALYSIS OF REPORTS ON ADVERSE REACTIONS AND POOR EFFICACY OF MEDICINES IN LVIV REGION FOR THE PERIOD OF 2018-2020
by: Nataliya Stepanyuk, et al.
Published: (2021-12-01)

Adverse Drug Reactions Reported in Healthcare Settings Affiliated to Mazandaran University of Medical Sciences, 2019-2021
by: Mina Amini, et al.
Published: (2023-09-01)

Adverse drug reaction reporting for more than a decade: The need for pharmacovigilance policy implementation in Turkey
by: Zakir Khan, M.Phil, et al.
Published: (2022-04-01)

Knowledge, attitude and perception/practices (KAP) of medical practitioners in India towards adverse drug reaction (ADR) reporting
by: Mala Kharkar, et al.
Published: (2012-01-01)

Adverse events in patients with leprosy on treatment with thalidomide
by: Paula Lana de Miranda Drummond, et al.
Published: (2019-04-01)

Suspected Adverse Drug Reactions in Pediatric Cancer Patients in China: An Analysis of Henan Province Spontaneous Reporting System Database
by: Zhiming Jiao, et al.
Published: (2021-12-01)

Knowledge, attitude and practices of pharmacovigilance and adverse drug reaction reporting among pharmacists working in secondary and tertiary governmental hospitals in Kuwait
by: Fatemah M. Alsaleh, et al.
Published: (2017-09-01)

Corrigendum: Suspected Adverse Drug Reactions in Pediatric Cancer Patients in China: An Analysis of Henan Province Spontaneous Reporting System Database
by: Zhiming Jiao, et al.
Published: (2022-02-01)

ON THE ISSUE OF SAFETY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
by: N. Yu. Velts, et al.
Published: (2018-09-01)

Cutaneous adverse drug reactions in a tertiary care setup: A cross-sectional observational single-center-based study in Eastern India
by: Ritika Singh, et al.
Published: (2023-01-01)

Knowledge, attitude, practices, and barriers regarding pharmacovigilance and adverse drug reaction reporting among medical and dental faculties of the teaching hospitals in Bhubaneswar City
by: Avinash Jnaneswar, et al.
Published: (2020-01-01)